Literature DB >> 7921058

Private versus social opportunity cost of time: valuing time in the demand for health care.

D J Torgerson1, C Donaldson, D M Reid.   

Abstract

In this paper we examine whether the current method of valuing time within economic appraisals is appropriate. The cost to society of time taken to use health care may differ from the private opportunity cost of such time. However, demand for health care may be affected by the private opportunity time cost and not by the value of time to society. In this paper we show that the private opportunity cost of time is a better predictor of demand for a screening service than the societal approach. It is important, therefore, to use the private opportunity cost of time when assessing the demand for, and impact of, a health care intervention.

Mesh:

Year:  1994        PMID: 7921058     DOI: 10.1002/hec.4730030304

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  12 in total

1.  Willingness to pay for mammography: item development and testing among five ethnic groups.

Authors:  T H Wagner; T W Hu; G V Dueñas; R J Pasick
Journal:  Health Policy       Date:  2000-09       Impact factor: 2.980

Review 2.  Volume of clinical activity in hospitals and healthcare outcomes, costs, and patient access.

Authors:  A Sowden; V Aletras; M Place; N Rice; A Eastwood; R Grilli; B Ferguson; J Posnett; T Sheldon
Journal:  Qual Health Care       Date:  1997-06

3.  The Magnitude, Share and Determinants of Private Costs Incurred by Clients (and Their Caregivers) of In-home Publicly Financed Care.

Authors:  Vivian W Leong; Denise N Guerriere; Ruth Croxford; Peter C Coyte
Journal:  Healthc Policy       Date:  2007-08

4.  Calculating the cost of asthma in Canada.

Authors:  W Ungar
Journal:  CMAJ       Date:  1996-10-01       Impact factor: 8.262

5.  Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid.

Authors:  M Sculpher; M K Palmer; A Heyes
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

6.  Economic evaluation of multiple sclerosis in the UK, Germany and France.

Authors:  N Murphy; C Confavreux; J Haas; N König; E Roullet; M Sailer; M Swash; C Young; J L Mérot
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

7.  The Ambulatory and Home Care Record: A Methodological Framework for Economic Analyses in End-of-Life Care.

Authors:  Denise N Guerriere; Peter C Coyte
Journal:  J Aging Res       Date:  2011-05-19

8.  Just how much does it cost? A cost study of chronic pain following cardiac surgery.

Authors:  Jason Robert Guertin; M Gabrielle Pagé; Jean-Éric Tarride; Denis Talbot; Judy Watt-Watson; Manon Choinière
Journal:  J Pain Res       Date:  2018-11-08       Impact factor: 3.133

Review 9.  What cost components are relevant for economic evaluations of palliative care, and what approaches are used to measure these costs? A systematic review.

Authors:  Clare Gardiner; Christine Ingleton; Tony Ryan; Sue Ward; Merryn Gott
Journal:  Palliat Med       Date:  2016-09-27       Impact factor: 4.762

10.  Health Seeking Behavior among Rural Left-Behind Children: Evidence from Shaanxi and Gansu Provinces in China.

Authors:  Hongyu Guan; Huan Wang; Juerong Huang; Kang Du; Jin Zhao; Matthew Boswell; Yaojiang Shi; Mony Iyer; Scott Rozelle
Journal:  Int J Environ Res Public Health       Date:  2018-04-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.